A technical assessment of the consumer blood panel companies: who runs the assays, what the $349-$499 membership buys, how to get structured data out, and why a 100-biomarker panel flags something for almost everyone.
What a blood biomarker test measures, what it costs, how to get the numbers out in a form you can compute on, and the math that tells you whether a change between two draws is real.
A specific panel for athletes, the timing rules that make the numbers interpretable, the reference-change arithmetic that tells you when a shift is real, and how to get the data out of the lab in a computable form.
A working list of blood biomarkers that change decisions, why panel size is a poor proxy for value, and how to handle biological variation so you don't chase noise.
A direct look at what a maximal blood panel contains, which assays add real information, where the marketing exceeds the biology, and how to get the raw data in a form you can analyze yourself.
There is no single lifespan blood test. There is a small set of analytes that, combined, predict all-cause mortality better than any one of them, and a way to order, store, and recompute them so the numbers mean something over time.
There is no single 'Huberman blood test.' Here is the panel that gets discussed on the podcast, which markers carry real signal, and how to get the data in a form you can analyze yourself.